Aim: Abnormal daily sleep duration and quality have been linked to hypertension, diabetes, stroke, and overall cardiovascular disease (CVD) morbidity& mortality. However, the relationship between daily sleep duration and quality with subclinical measures of CVD remain less well studied. This systematic review evaluated how daily sleep duration and quality affect burden of subclinical CVD in subjects free of symptomatic CVD. Results: Subjective short sleep duration was associated with CAC and CIMT, but variably associated with endothelial dysfunction (ED) and arterial stiffness; however, subjective long sleep duration was associated with CAC, CIMT and arterial stiffness, but variably associated with ED. Objective short sleep duration was positively associated with CIMT and variably with CAC but not associated with ED. Objective long sleep duration was variably associated with CAC and CIMT but not associated with ED. Poor subjective sleep quality was significantly associated with ED and arterial stiffness but variably associated with CAC and CIMT. Poor objective sleep quality was significantly associated with CIMT, and ED but variably associated with CAC. Conclusions: Overall, our review provided mixed results, which is generally in line with published literature, with most of the studies showing a significant relationship with subclinical CVD, but only some studies failed to demonstrate such an association. Although such mechanistic relationship needs further evaluation in order to determine appropriate screening strategies in vulnerable populations, this review strongly suggested the existence of a relationship between abnormal sleep duration and quality with increased subclinical CVD burden.
CVD markers need to be studied in more detail. As early recognition of subclinical CVD in people with sleep disturbances may impact risk stratification and early treatment of subclinical CVD before the development of clinical CVD events.
The purpose of this systematic review is to evaluate the following: First the relationship between selfreported or/and objectively assessed sleep duration with markers of subclinical CVD. Second, the relationship between self-reported or/and objectively assessed sleep quality with markers of subclinical CVD. Third, the effect of acute and chronic sleep deprivation on subclinical CVD risks. Such association of sleep parameters with subclinical CVD would provide the importance of regular sleep habits and would provide evidence to the stakeholders to consider sleep disturbances as important risk factors for determination of future risk of CVD events. This systematic review may also highlight the role of noninvasive cardiovascular diagnostic procedures in those with sleep disturbances.
Methods
An electronic systematic literature search was performed using the EMBASE (via EMTREE) and Medline database (National Library of Medicine, Bethesda, MD via PubMed) for relevant literature up to March 2016 (Fig. 1) . We used both MeSH and Emtree terms and relevant free text terms. The following search terms (synonyms and combinations) were used: "sleep duration" and/or "sleep quality". These terms were combined with "sub clinical cardiovascular disease risks", "coronary artery calcium (CAC)", "carotid intima-media thickness (CIMT)", "endothelial function and/or microvascular function via flow mediated dilation (FMD) and/or peripheral arterial tone (PAT) and/or iontophoresis and/or nailfold capillaroscopy", and "arterial stiffness via pulse wave velocity (PWV)", and/or ankle brachial index (ABI)".
The search results were manually scanned for relevant articles by three independent reviewers. References of obtained articles were used for additional articles. The search was limited to original research studies on human subjects published in English language. We included (1) original research articles, AND (2) studies that reported subjective and/or objective sleep duration AND/OR (3) studies that reported subjective and/or objective sleep quality, AND (4) studies that reported PSQI good vs PSQI bad sleep quality and/or insomnia vs. non-insomnia and/or shift vs. non-shift work and/or arousal index and/or sleep efficiency (%) and/or sleep Fragmentation index and/ or REM/Non-REM sleep, AND (5) studies that reported an assessment of Non-Invasive Subclinical
Introduction
A good hygienic sleep is an essential part of everyday life. It is estimated that humans spend one third of their lifetime sleeping. An estimated 50 -70 million Americans suffer from sleep disorders, yet only 20% report it to their physicians 1) . Poor sleep may be a risk factor for cardiovascular disease (CVD) and has serious biological consequences 2) . A growing body of literature suggests a relationship of sleep parameters (sleep duration and sleep quality) with CVD, stroke, and all-cause morbidity & mortality 3) . A recent review of 23 studies determined that both short and long sleep is related to increased risk for all-cause mortality among both men and women, compared to individuals who report a medium amount of daily sleep (7 -8 hours) 4) , however, some studies have shown that the sleep disturbances may be associated with CVD mortality with weaker evidence for women 5) . Additionally, acute and chronic sleep deprivation can lead to weight gain, impaired glucose tolerance, activate pro-inflammatory pathways, increased sympathetic activity and higher cortisol levels in healthy subjects 6) . The epidemiological data suggests strong association of subjectively and/or objectively measured sleep parameters with classical CVD risk factors like hypertension, insulin resistance, hypercholesterolemia, type 2 diabetes and increase in the inflammatory markers leading to subclinical and clinical CVD [7] [8] [9] [10] . The traditional risk stratification has relied mainly on scoring systems such as the Framingham risk score to determine the CVD risks 11) . However, newer non-invasive techniques that assess coronary artery calcium (CAC), carotid intima-media thickness (CIMT), flow-mediated dilation (FMD), Ankle Brachial Index (ABI) and pulse wave velocity (PWV) provide refined assessment of early atherosclerosis process, endothelial dysfunction and arterial stiffness potentially leading to clinical CVD events. The extent of CAC and CIMT correlates with plaque burden and atherosclerosis, decreased FMD correlates with endothelial dysfunction, decreased ABI but increased PWV measure increasing arterial stiffness [12] [13] [14] [15] . There are some studies that show relationship of these non-invasive subclinical CVD markers with disturbed sleep parameters 16, 17) and signify the importance of regular sleep habits but such relationships between the sleep parameters and subclinical (angina, myocardial infarction and heart failure) and cerebrovascular diseases (stroke) (4) the studies that that have discussed the effect of mental disorders on sleep duration and sleep quality (5) the studies in which participants used any kind of sleeping pills. Thirty-two studies met the inclusion criteria for final review from an initial search result of 186 articles ( Fig. 1 for search algorithm) . The authors stated that no financial support was given and that no off-label or investigational use of a drug or device was performed as part of this research.
Sleep duration typically defines as "the total amount of sleep obtained, either during the nocturnal sleep episode or across the 24-hour period" 19) . In the studies discussed in this review, the sleep duration was CVD assessment tools as Coronary Artery Calcium (CAC) and/or Carotid Intima Media Thickness (CIMT) and/or Endothelia function and/or Arterial stiffness. The aim of this review was to summarize the evidence of regular daily sleep duration and sleep quality with subclinical CVD, so we excluded any study that discussed the association of sleep disorders and clinical cardiovascular and cerebrovascular diseases. Many research studies have shown that sleep disorders like obstructive sleep apnea has been previously shown to be strongly associated with subclinical CVD 18) . In our exclusion criteria, we excluded (1) the letters, editorials (2) the studies on subjects with sleep disorders [obstructive sleep apnea (OSA), parasomnias, and narcolepsy] (3) the studies that discussed clinical CVDs whereby the objective sleep quality is defined not only by sufficient duration, high efficiency, and low fragmentation, but also by proper staging of sleep (i.e., cycling through non-REM (stages 1 -4) and REM) 23) . In this review, the sleep quality was measured via subjective methods, including Pittsburg Sleep Quality Index (PSQI) and/or self-reporting of insomnia vs non-insomnia, shift vs non-shift work, arousal index, or via objective measures, which include actigraphy and/or polysomnography or by both subjective and objective methods 20, 21) . The Pittsburgh Sleep Quality Index (PSQI) is an effective tool used to measure the quality and patterns of sleep in adults. It differentiates "poor" from "good" sleep quality by measuring seven measured either via subjective methods, including selfreported questionnaires and/or Pittsburg Sleep Quality Index (PSQI) or via objective measures, which include actigraphy and/or polysomnography or by both subjective and objective methods 20, 21) . The subjective sleep quality is defined as "one's perception that they fall asleep easily, get sufficient duration so as to wake up feeling rested, and can make it through their day without experiencing excessive daytime sleepiness" 22) . Using actigraphy to objectively measure sleep quality, the objective sleep quality is defined by sufficient duration ( 7 hrs), high efficiency ( 85%), and low fragmentation ( 25) 23) . Using polysomnography (PSG) the sleep architecture is added to the equation, (Cont Table 1 . Among subclinical cardiovascular disease (CVD) measures, the coronary artery calcium (CAC) was measured by either electron beam computed tomography (EBCT) or multidetector computed tomographic (MDCT) scanner. Increased calcium deposition in coronary arteries is related to the presence of atherosleep components that include subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction over the last month 24) . Sleep fragmentation is defined as "an index of restlessness during the sleep period expressed as a percentage". It is calculated as movement index, a fragmentation index, and total sleep fragmentation Index. The higher a Adjusted for race, sex, age, smoking, education, and apnea risk b Adjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate. c Adjusted for race, sex, age, smoking, education, apnea risk, BMI, HDL, LDL, BP, DM chial, radial or femoral arteries. The decrease in the flow mediated dilatation is closely related to endothelial cells dysfunction that leads to increased risk of vessels wall injury causing both the early and late mechanisms of atherosclerosis that include increased leukocyte adherence, platelet activation, and vascular smooth muscle proliferation and decreased production of nitric oxide 14) . The PAT is calculated by EndoPAT device (Itamar Medical, Israel) that involves measuring the pulse amplitude in the fingertip at rest and following the induction of reactive hyperemia. The EndoPAT device consists of a fingertip plethysmograph capable sclerotic process and increased plaque burden 12) . The carotid intima-media thickness (CIMT) was measured using high-resolution B-mode ultrasonography on carotid arteries and increased intima media thickness in carotid artery is related to carotid atherosclerosis and future increased risk of CVD 13) . The endothelial function and/or microvascular function was measured by flow mediated dilation (FMD) and/or peripheral arterial tone (PAT) and/or iontophoresis and/or nailfold capillaroscopy. The FMD is based on an ultrasound test that measures the changes in the arterial diameter based on their blood flow such as the bra- third finger is used to determine the endothelial function. The measurements are conducted after at least 30 min of rest and with a minimum hand temperature of 28 . The microvascular measurements include the duplicate measurements of capillary density at the base of the interphalanx at rest and after 4 min of arterial occlusion 28) . The arterial stiffness was measured via pulse wave velocity (PWV), and/or ankle brachial index (ABI). The PWV is the time the arterial pressure wave takes to travel a distance between two arterial sites and is measured distance (cm)/time (seconds). Higher value of PWV is directly correlated to the arterial stiffness and when measured over the aorta, it represents an independent risk factor for increased cardiovascular disease 15) . There are different methods to measure the PWV that include brachial artery PWV (baPWV), carotid-femoral PWV (cfPWV), heart-femoral PWV (hfPWV) and femoral-ankle PWV of sensing volume changes in the digit with each arterial pulsation. The volume changes in the fingertip are documented digitally as pulse amplitude that can be tracked over time. The expected response is a post occlusion increase of the PAT signal amplitude and the PAT score is provided automatically by the system's software and is basically the ratio between the post-to pre-occlusion average signal size, corrected for systemic changes and baseline level 26) . Iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP) is a tool used to determine microvascular endothelial function. Two laser-Doppler probes specifically designed with an embedded sponge for skin iontophoresis of agonists are fixed 5 cm apart to the skin with an adhesive patch to measure the endothelium-dependent and endothelium-independent vasodilatation to determine the endothelial function 27) . The nailfold capillary video microscopy of the dorsal skin of the 
Results
Thirty-two studies met the final selection criteria and discussed the relationship of subjective (self-report) and objective (actigraphy and/or polysomnography) sleep duration as well as subjective and objective sleep quality with non-invasive markers of subclinical CVD. Sleep duration and sleep quality are two distinct parameters of sleep, and these are discussed separately along with each non-invasive marker of subclinical CVD in respective tables. Five studies evaluated association of sleep parameters with coronary artery calcium (CAC) 17, [31] [32] [33] [34] , eight evaluated association with carotid intima-media thickness (CIMT) 2, [35] [36] [37] [38] [39] [40] [41] , thirteen evaluated association with endothelial func-(faPWV) and these reflect properties of central, peripheral or mixed properties of both central and peripheral arterial stiffness. All studies used in this review discussed the relationship of sleep parameters with baPWV which is considered as an important parameter of both central and peripheral arterial stiffness 29) . ABI is a measure reflective of systemic atherosclerosis and predict the stiffness in the vessels. The ABI is the ratio of the systolic blood pressure at the ankle to the average systolic blood pressure at the right arm. The lower the value of ABI below 1.0 correlates with the severity of arterial stiffness 30) .
(Cont robust with only one study among the total of three showed that poor sleep quality is associated with increased CAC among women only. Objective sleep quality only in the form of arousal index was directly associated with increased CAC as, higher the arousal index, higher the risk of being in a CAC group of CAC ≥ 400 Agatston units (Table 2b) Association of Subjective and Objective Sleep Parameters with Carotid Intima Media Thickness (CIMT) Table 3a showed that subjective and objective sleep duration were associated with CIMT with stronger evidence present for shorter sleep duration with increased CIMT as compared with reference sleep hours (6 -8 hours). The population used in these studies was heterogeneous with mostly elderly and police officers. Among all studies assessing the CIMT, the sleep duration group of average 7 hours exhibited lowest systolic blood pressure and Hemoglobin A1c. Table 3b showed that most of the studies discussed the relationship of subjective sleep duration with CIMT. Only one study discussed association of tion [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] , and six studies assessed relationship with arterial stiffness 17, [55] [56] [57] [58] . Kim et al. 2015 studied both the subjective sleep duration and subjective sleep quality with both CAC as well as PWV in same paper so the results of CAC and PWV outcomes were stated separately in the relevant tables 17) . Table 1 shows the baseline characteristics of all the studies used in this review. Table 2a shows the association of subjective and objective sleep duration with CAC. Kim et al. showed that association of subjective sleep duration with CAC is "U" shaped with stronger association of short subjective sleep duration with increased CAC. King et al. showed that objective longer sleep duration is better predictor of CAC as compared to objective shorter sleep duration with 0.66 times increase in CAC with each hour increase in sleep duration. All other studies did not show any significant association of sleep duration with CAC.
Association of Subjective and Objective Sleep Parameters with Coronary Artery Calcium (CAC)
The association of sleep quality with CAC is less Table 5a discussed the association of subjective sleep duration with arterial stiffness. All studies showed that subjective long sleep duration was associated with increased arterial stiffness; however, only one study showed a relationship between subjective short sleep duration and arterial stiffness and other studies failed to demonstrate such association.
Association of Subjective and Objective Sleep Parameters with Arterial Stiffness
In Table 5b , all studies that discussed the subjective association of sleep quality with arterial stiffness, showed a strong positive association of bad sleep quality with arterial stiffness in terms of increased brachial artery pulse wave velocity (baPWV) and decreased ankle brachial index (ABI). There was no study in this review that reported the association of objective sleep quality with arterial stiffness.
Discussion
This systematic review investigated the association of subjectively and/or objectively measured sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD). According to this review, subjective short sleep duration was associated with CAC and CIMT, but variably the objective sleep quality with CIMT and it was significant (p ≤ 0.05). Among these studies insomnia was strongly associated with CIMT as compared to noninsomnia. PSQI as a parameter of sleep quality was discussed only in two studies and was significant only in one study ( 0.22, p 0.05). Table 4a discussed the subjective and objective sleep duration with endothelial functions. Among total of five studies, only one study discussed the objective sleep duration and endothelial functions and it was not significant. Among the other four studies, only two studies showed the significant association of subjective sleep duration with endothelial dysfunctions. Table 4b discussed the subjective and objective sleep quality with endothelial functions. Most of the studies showed a significant association of low sleep quality with reduced endothelial functions. The low sleep quality was expressed variably in these studies by PSQI quality scores, acute sleep deprivation, difficulties initiating sleep or maintaining sleep, REM sleep, REM latency, noise level during sleep, chronic stress vs no stress, shift vs. non-shift workers. ing that both short and long sleep durations were associated with a greater relative risk of coronary heart disease and stroke 60) . Sleep quality as assessed by insomnia and sleep deprivation have also been linked with adverse CVD outcomes. Westerlund et al. revealed that insomnia itself was not related to CVD risk, but when considered together with short sleep duration, there was a higher risk of overall cardiovascular events 3) . The exact mechanism by which compromised sleep quality lead to CVD is not clear, but possible explanations include changes in hormones and inflammatory markers, lipid levels, glucose tolerance/metabolism, sympathetic nervous system and subclinical atherosclerosis 61) . Cappuccio et al. performed another systematic review and meta-analysis in 2010 of 10 cohort studies showing that sleep ≤ 5 -6 h and 8 -9h were associated with higher relative risk of developing Type 2 DM 62) . Gangwisch et al. showed associated with endothelial dysfunction (ED) and arterial stiffness, however subjective long sleep duration was associated with CAC, CIMT and arterial stiffness, but variably associated with ED. Objective short sleep duration was positively associated with CIMT, variably with CAC but not associated with ED. Objective long sleep duration was variably associated with CAC and CIMT but not associated with ED. Poor subjective sleep quality was significantly associated with ED & arterial stiffness but variably associated with CAC& CIMT. Poor objective sleep quality was significantly associated with CIMT, and ED but variably associated with CAC (Table 6) There is a growing body of literature linking sleep duration with CVD outcomes. Sabanayagham et al. revealed a higher odds of myocardial infarction and stroke in subjects that slept ≤ 5 h and ≥ 9h 59) . In 2011, Cappuccio et al. performed a systematic review show- There were no significant effects of day, time, group, or interactions on%FMD among both shift and non-shift workers.
Association of Subjective and Objective Sleep Parameters with Endothelial Functions
Only male sample
Strand et al. The endothelium-dependent and -independent cutaneous vascular conductance were significantly decreased after 29 h of TSD (P ≤ 0.05).
40 hours of total sleep deprivation.
Bonsen et al. . According to a review by Elliott et al. sleep deprivation can cause death sooner than food deprivation in both Drosophila and rats, further favoring importance of regular sleep habits 67) . Our review provided mixed results in terms of subjective and/or objective short and/or long sleep duration and sleep quality with sub-clinical CVD, with a greater percentage of studies showing a relationship with sub-clinical CVD. However, only some studies in this review failed to demonstrate such an association 31, 32, 37, 43) and one possible reason for such results could be due to the use of subjective/self-report versus objectively measured sleep parameters to assess the association with subclinical CVD causing biased results. Lauderdale et al. found a correlation between self-reported and objectively measured sleep duration of 0.45, which is generally considered as a moderate correlation. In current review, while one study reports a "J-shaped" association 35) , the other two study reports a "U-shaped" association 17, 37) between sleep duration and sub-clinical CVD outcomes. Some studies report a positive association of sleep duration with sub-clinical CVD only with short sleep duration; some only with long sleep duration; some studies show a positive assothat ≤ 5 hours of sleep significantly increased the risk of hypertension 63) . Dettoni et al. showed that five nights of partial sleep deprivation can significantly cause a trigger in the sympathetic activity and venous endothelial dysfunction and this evidence is in alignment with the association between short sleep and increased cardiovascular risk in other epidemiological studies 50) . Many animal studies have also found sleep deprivation causes an increase in endothelin levels. Endothelin is a potent vasoconstrictor that has been implicated in the pathogenesis of hypertension 64) . MeierEwert et al. revealed that both total (88 hrs of no sleep) and short-term partial sleep (4.2 hrs of sleep) deprivation resulted in elevated high-sensitivity CRP concentrations, compared to those who slept 8.2 hours 65) . Sauvet et al. demonstrated that total sleep deprivation in rats induces a reduction in endothelialdependent vasodilation independent of blood pressure and sympathetic activity 64) . Carreras et al. showed in mice that long-term sleep fragmentation lead to vascular endothelial dysfunction, mild increase in blood pressure, vascular elastic fiber disruption and disorganization, and increased recruitment of inflammatory (Cont Table 4b of subclinical CVD burden due to changes in the sleep parameters in specific age groups and gender. Our systematic review findings need to be considered in light of the following limitations. The metaanalysis for this review is not applicable because the studies included in our review are highly heterogeneous in population, outcome reporting and sleep duration and quality assessment groups, precluding a quantitative or meta-analytical synthesis of evidence. Some studies reported only subjective measures of sleep duration and sleep quality, some only objective measures, and some both. Not all studies used similar/ standardized subjective and objectives measures of sleep duration and quality. Some studies used simple questionnaire to measure sleep duration and quality, some used Pittsburgh Sleep Quality Index (PSQI), some used actigraphy and some used polysomnography creating further heterogeneity in assessment of predictor variable. Furthermore, the reference/control sleep duration used in these studies was not a stanciation with both short and long duration 33, 38, 39, 57) but almost all studies favor the duration of the reference sleep (average 6 -8 hours of regular daily sleep). To our surprise, some studies have even shown long sleep hours is related to decrease in CAC 33) , decrease in CIMT [38] [39] [40] , decrease in PWV 56) and one study by Yoshioka et al. 55) even showed that sleep duration of ≤ 6 hours was associated with a significant decrease in PWV and thus produced a great source of heterogeneity in the review. Although most of the studies in the current review demonstrate that sleep parameters are associated with early sub-clinical CVD, there is, as yet, no consensus on the biological pathways linking these processes. It is entirely possible, given the complexity of factors responsible for sleep habits that sleep disturbances may be an epiphenomenon of subclinical and clinical CVD rather than the proximate cause 1) . The population used in these studies is highly heterogeneous based on age and gender differences, and thus no consensus can be made about the particular nature Not even a single study have described the association of objective sleep duration with Arterial Stiffness. m Adjusted for age, sex, SBP, hypertension, HR, biological risk factors (BMI, TC, log TG, HDL-C, and FBS), lifestyle factors (education, exercise, smoking, and alcohol consumption), and occupational factors (occupation, working hours, shift work, days off, and job strain) n Adjusted for age, BMI, eGFR, Hypertension, DM, TC/HDL-C, sleep duration, smoking, alcohol drinking, regular exercise, and snoring ≥ 3/week b Adjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate. specific age group are needed to further clarify this concern. Furthermore, ethnic-specific variations in sleep parameters and association with subclinical CVD have not been discussed and compared in these studies and thus question the need of further studies discussing the comparison of subclinical CVD burden in the multi-ethnic populations. Another concern is that most of the studies used in this review are cross sectional and as a result, causality cannot be determined. Our findings show the need for follow up studies to assess the rapid progression of subclinical CVD with sleep disturbances. This will further clarify the association of sleep parameters with an increased subclinical and clinical CVD burden. Finally, the implications of the associations demonstrated in our review are unclear. Should individuals with sleep disturbances be considered candidates for subclinical CVD screening? Most sleep disturbance treatment focuses on lifestyle modification, which is beneficial for CVD. However, in scenarios where one is found to have these findings, should one be a candidate for aggressive preventive pharmacotherapy such as Statins ? What will be the dardized duration, some studies used 6 hours as reference sleep duration, some used 7 hours, some used 8 hours and some studies even used 6 -8 hours as reference sleep duration. The assessment of subjective and objective sleep quality was also different among the studies used in this review. Some studies used insomnia vs. non-insomnia, some used shift vs non-shift work, some used fragmentation index and/or arousal index and/or REM/Non-REM sleep to assess the sleep quality. A few studies that examined both subjective and objective sleep parameters demonstrated different outcomes depending on the nature of the predictor variable used in their analysis (subjective versus objective).
Some of the studies included in our review are of questionable methodological quality, which may be another source of observation bias. The population discussed in this systematic review ranges from 20 to 87 years and due to heterogeneous nature of these studies we could not conclude what age groups were at more risk of subclinical CVD based on their sleep disturbances, thus more focused studies directed to Lower the ABI, more the arterial stiffness.
Objective Sleep Quality
Not even a single study have described the association of objective sleep Quality with Arterial Stiffness.
b Adjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate. o Adjusted for age, gender, BMI, morningness eveningness questionnaire, Beck Depression inventory, energy intake, alcohol intake, current smoking, physical activity, systolic BP, HbA1c, total cholesterol, HDL-cholesterol, triglyceride and sleep duration population.
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Conclusion
In conclusion, based on our systematic review, individuals with sleep disturbances, both quantitative and qualitative, have an accelerated subclinical CVD burden in the form of augmented Coronary Artery Calcium (CAC), increased Carotid Intima Media Thickness (CIMT), impaired endothelial function, and augmented arterial stiffness. Table 6 provides a snapshot of association of non-Invasive Subclinical CVD assessment tools with sleep duration and sleep quality. These findings suggest that association between sleep disturbances and increased CVD risk is exemplified by early changes in sub-clinical CVD status. Important issues that need further exploration include the public awareness of regular sleep habits, and potential consequences of compromised sleep duration and quality in terms of causing hypertension, high cholesterol and risk of diabetes. There is a need to identify appropriate screening and treatment strategies across different group of populations with sleep disturbances and whether these preventive approaches can slow progression of sub-clinical CVD and reduction in clinical events. Comprehensive studies aimed at answering these key questions can facilitate generation of information to guide preventive efforts in this 
